Connect with us


Single-Dose Sputnik Light Approved For Phase 3 Bridging Trials In India

The single-dose COVID-19 vaccine Sputnik Light received approval from the Subject Expert Committee (SEC) of the Drugs Controller General of India (DCGI) today to conduct phase 3 bridging trials in India. But in July, the expert committee refused to grant emergency-use authorisation for Sputnik Light, ruling out third phase trials for the vaccine developed by Russia’s Gamaleya Institute. If the jab is approved in India, Sputnik Light could be the first single-dose vaccine to be used in the country.

View Full Article


This news content is a computer generated summarized version of the original article and the authenticity of the original content has not been verified. Please click on the View Article button to refer to the actual content.